Beilu Pharma: Iodixanol raw material drug has obtained registration certificate in India
I'm LongbridgeAI, I can summarize articles.Beilu Pharma's subsidiary Zhejiang Haichang Pharmaceutical recently obtained the raw material drug registration certificate for Iohexol issued by the Central Drugs Standard Control Organization of India. This marks the product's qualification for market access in India, allowing it to be sold in the country, and is expected to actively promote Haichang Pharmaceutical's expansion in the international market
According to the Zhitong Finance APP, Beilu Pharma (300016.SZ) announced that recently, its holding subsidiary Zhejiang Haichang Pharmaceutical Co., Ltd. (hereinafter referred to as "Haichang Pharmaceutical") received the raw material drug product registration certificate for Iohexol issued by the Central Drugs Standard Control Organisation of the Ministry of Health & Family Welfare of India.
The registration certificate for Haichang Pharmaceutical's Iohexol raw material drug product marks that the product has obtained market access qualification in India, allowing Iohexol raw material drugs to be sold in the Indian market, which will have a positive impact on Haichang Pharmaceutical's further expansion into international markets